clinical trial · NCT07844070
A Study of Disease Modifying Therapy Use in Women With Multiple Sclerosis Before, During, and After Pregnancy
Multiple Sclerosis
brief summary
This study aims to assess the real-world patterns of disease modifying therapy (DMT) use before, during, and after pregnancy in women with multiple sclerosis (MS). The study will use a pooled closed claims database containing closed payer medical and pharmacy claims data for patients in the United States (US).
started
Mar 6, 2026
primary completion
Oct 30, 2026
completion
Oct 30, 2026
last updated
Nov 19, 2026
official title
Disease Modifying Therapy Use in Women With Multiple Sclerosis Before, During, and After Pregnancy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol